Business Context and Reporting Period
This Form 8-K filing by Oaktree Acquisition Corp. III Life Sciences (a Cayman Islands emerging growth company) reports a material corporate event occurring on October 29, 2025. The Company is a special purpose acquisition company (SPAC) focused on the life sciences sector, with securities trading on The Nasdaq Stock Market LLC under the symbols OACCU, OACC, and OACCW.
Key Financial Metrics
This filing is a current report regarding executive personnel changes and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes
The filing discloses a significant change in the Company's executive leadership:
- Resignation: Thomas Sweeney resigned as Chief Financial Officer (CFO) effective October 29, 2025. The resignation was voluntary to pursue other professional opportunities and was not the result of any disagreement with the Board or management.
- Appointment: George A. Martinez was appointed as the new Chief Financial Officer (principal accounting and principal financial officer) effective immediately on October 29, 2025.
Management Commentary and Compensation
Mr. Martinez is a Senior Vice President within Oaktree Capital Management, L.P.'s finance organization, with prior experience as an Audit Senior Manager at Ernst & Young. Notably, Mr. Martinez will not be compensated by the Company for his services as CFO and has not entered into an employment agreement. He is expected to execute standard Indemnity and Letter Agreements consistent with other directors and officers. The filing confirms no family relationships exist between Mr. Martinez and other Company directors or officers.
Investor Verification Checklist
- Verify the transition timeline for financial reporting responsibilities between the outgoing and incoming CFO.
- Confirm the status of the Company's search for a business combination given the leadership change.
- Review the upcoming Form 10-K or 10-Q filings for the first financial data reflecting the new CFO's tenure.
- Check for any subsequent filings regarding the execution of Mr. Martinez's Indemnity and Letter Agreements.